Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Marcus

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Haematology|November 3, 2017
A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantationFeras Al Fararjeh, Shameem Mahmood, Phaedra Tachtatzis, et al.
Hemasphere|March 2, 2022
Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM TrialMichael Herold, Eva Hoster, Ann Janssens, et al.
Leukemia & Lymphoma|January 18, 2017
Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre studyVijay Dhanapal, Menaka Gunasekara, Chia Lianwea, et al.
Blood|October 21, 2004
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphomaRobert Marcus, Kevin Imrie, Andrew Belch, et al.
Blood|March 28, 2007
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantationFranck Morschhauser, Tim Illidge, Damien Huglo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or TeriparatideKenneth G Saag, Donato Agnusdei, Didier Hans, et al.
AIDS (London, England)|March 3, 2015
Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapyFerras Alwan, Annie He, Silvia Montoto, et al.
Blood|January 29, 2021
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphomaChristopher R Bolen, Federico Mattiello, Michael Herold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphomaRobert Marcus, Kevin Imrie, Philippe Solal-Celigny, et al.
Leukemia & Lymphoma|December 5, 2012
A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphomaShireen Kassam, Mark Bower, Siow Ming Lee, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Haematology|November 3, 2017
A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantationFeras Al Fararjeh, Shameem Mahmood, Phaedra Tachtatzis, et al.
Hemasphere|March 2, 2022
Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM TrialMichael Herold, Eva Hoster, Ann Janssens, et al.
Leukemia & Lymphoma|January 18, 2017
Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre studyVijay Dhanapal, Menaka Gunasekara, Chia Lianwea, et al.
Blood|October 21, 2004
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphomaRobert Marcus, Kevin Imrie, Andrew Belch, et al.
Blood|March 28, 2007
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantationFranck Morschhauser, Tim Illidge, Damien Huglo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or TeriparatideKenneth G Saag, Donato Agnusdei, Didier Hans, et al.
AIDS (London, England)|March 3, 2015
Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapyFerras Alwan, Annie He, Silvia Montoto, et al.
Blood|January 29, 2021
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphomaChristopher R Bolen, Federico Mattiello, Michael Herold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphomaRobert Marcus, Kevin Imrie, Philippe Solal-Celigny, et al.
Leukemia & Lymphoma|December 5, 2012
A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphomaShireen Kassam, Mark Bower, Siow Ming Lee, et al.
Pageof 10